Nektar Therapeutics reported $665.54M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Amgen AMGN:US $ 19322M 802M
Astrazeneca AZN:US 20.92B 1.73B
Baxter International BAX:US $ 7882M 291M
Biogen BIIB:US $ 9740.9M 1825M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Cara Therapeutics CARA:US $ 176.17M 24.4M
Eisai 4523:JP Y 620947M 19659M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Esperion Therapeutics ESPR:US $ 252.48M 38.34M
Exelixis EXEL:US $ 1851.64M 8.9M
Gilead Sciences GILD:US $ 13705M 1076M
GlaxoSmithKline GSK:LN 5418.8B 2520B
Halozyme Therapeutics HALO:US $ 541.94M 446.75M
Immunogen IMGN:US $ 373.87M 82.84M
Ironwood Pharmaceuticals IRWD:US $ 617.83M 92.28M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Macrogenics MGNX:US $ 167.63M 50.57M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Novartis NOVN:VX 38.14B 906M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Seattle Genetics SGEN:US $ 2778.66M 7.4M
Takeda 4502:JP Y 2549515M 44127M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Xencor XNCR:US $ 585.94M 79.97M
YTE INCY:US $ 3625.84M 337.75M